Results 61 to 70 of about 6,936 (201)

Detailed analysis of X chromosome inactivation in a 49,XXXXX pentasomy

open access: yesMolecular Cytogenetics, 2009
Background Pentasomy X (49,XXXXX) has been associated with a severe clinical condition, presumably resulting from failure or disruption of X chromosome inactivation. Here we report that some human X chromosomes from a patient with 49,XXXXX pentasomy were
Menezes Albert N   +6 more
doaj   +1 more source

Metabolism‐Regulating Nanomedicines for Cancer Therapy

open access: yesAdvanced NanoBiomed Research, Volume 6, Issue 1, January 2026.
This review highlights metabolism‐regulating nanomedicines designed to target glycolytic, lipid, amino acid, and nucleotide pathways in tumors. By incorporating metabolism‐regulating agents into versatile nanocarriers such as liposomes, micelles, dendrimers, and engineered bacteria, these platforms achieve targeted delivery, controlled release ...
Xiao Wu, Shiyi Geng, Jian Yang
wiley   +1 more source

Change in CADESI and PVAS as a function of time in subjects treated with prednisolone and either placebo or LD-aminopterin.

open access: yes, 2014
Subjects treated with prednisolone (pred) in the first 14 days (N = 62) were treated with either placebo (N = 13), or LD-aminopterin once-weekly (0.007×1 mg/kg, N = 13; 0.014×1 mg/kg, N = 13; 0.021×1 mg/kg, N = 12) or twice-weekly (0.007×2 mg/kg, N = 11).
Alan Mundell (634763)   +5 more
core   +1 more source

Exploiting Salmonella Typhi Dihydrofolate Reductase (DHFR) For The Discovery of Novel Antibacterial Agents: An In-Silico Study

open access: yesNepal Journal of Biotechnology
Multidrug resistance trait acquired by Salmonella Typhi, the causative agent of typhoid fever in different parts of the world has exacerbated the treatment outcome of the disease creating more public health concern.
Abdulhafiz Lamiya   +4 more
doaj   +1 more source

The Creation of a Weight of Evidence Scoring Database for Risk Factors for Adverse Impacts to Birth Outcomes Using Expert Elicitation

open access: yesBirth Defects Research, Volume 118, Issue 1, January 2026.
ABSTRACT Background Adverse birth outcomes are important public health measures and account for a substantial public health burden. There is considerable diversity of these health endpoints, as well as in the many factors suspected or recognized to increase their risk.
Paul J. Villeneuve   +18 more
wiley   +1 more source

Study flow chart.

open access: yes, 2014
Randomized subjects with AD were orally administered placebo, or LD-aminopterin once-weekly (0.007×1 mg/kg, 0.014×1 mg/kg, 0.021×1 mg/kg) or twice-weekly (0.007×2 mg/kg).
Alan Mundell (634763)   +5 more
core   +1 more source

Development of a Sensitive Chemiluminescence Immunoassay for the Quantification of Folic Acid in Human Serum

open access: yesJournal of Analytical Methods in Chemistry, 2019
Folic acid (FA) is an important vitamin for human growth, especially for pregnant women. FA deficiency is associated with megaloblastic anemia, neural tube defects, cardiovascular diseases, irritability, diarrhea, and psychiatric disorders.
Xiang Chen   +7 more
doaj   +1 more source

Identification of novel Mycobacterium tuberculosis dihydrofolate reductase inhibitors through rational drug design

open access: yesInternational Journal of Mycobacteriology, 2016
Objectives/Background: Dihydrofolate reductase (DHFR) is one of the validated drug targets in Mycobacterium tuberculosis (Mtb) infection. DHFR inhibitors have been used to treat various life-threatening diseases such as cancer, malaria, and several ...
Mymoona Akhter
doaj   +1 more source

The In Vitro Transgenic Rodent Assay in Primary MutaMouse Hepatocytes Compared to the Mammalian Cell Gene Mutation Assay Using the HPRT Gene

open access: yesEnvironmental and Molecular Mutagenesis, Volume 67, Issue 1-2, January‐February 2026.
ABSTRACT Gene mutations can be detected in mammalian cells in vitro using indicator genes such as the hypoxanthine‐guanine‐phosphoribosyltransferase (HPRT) gene. These assays have been adopted as OECD test guidelines (TG, e.g., OECD TG no. 476) and are used for regulatory purposes.
Alina Göpfert   +5 more
wiley   +1 more source

Adult and two children with fetal methotrexate syndrome [PDF]

open access: yes, 1998
The folic acid antagonists, methotrexate and aminopterin, are known to be teratogenic in humans. The critical period for their teratogenecity is suspected to be between 6 to 8 weeks post-conception.
Conard, Joan V.   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy